SUBSCRIBE
SUBSCRIBE

Agenus Inc.

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
Agenus Trades Away Future Royalties on Sales of GlaxoSmithKline Drug for $115 Million
September 9, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Incyte Corporation, Agenus Strike $410 Million+ Immuno-Oncology Antibodies Pact
January 9, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update
November 6, 2024
 · 
2 min read
Business
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
June 17, 2024
 · 
4 min read
Genetown
Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
June 13, 2024
 · 
6 min read
Genetown
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 24, 2024
May 24, 2024
 · 
1 min read
Genetown
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024
 · 
4 min read
Genetown
Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024
 · 
1 min read
Drug Development
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
May 16, 2024
 · 
4 min read
Business
Agenus Reports First Quarter 2024 Results
May 7, 2024
 · 
9 min read
BioMidwest
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 7, 2024
 · 
11 min read
Deals
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 1, 2024
 · 
1 min read
Load More